Yes, in any of those discussions, the technical folks and the scientists are very conversant with the science, wherever it is coming from, and do scans all around the world.
Endocrine disrupters specifically and a number of other pharmaceuticals are on what I would call a watch-list. It's a long list of things that our technical groups are constantly reviewing and assessing so that when the time is right, which means when the science is available and when we have the ability to go at it, we will develop those guidelines.